Imbiologics Corp (493280)

Currency in KRW
18,550
-290(-1.54%)
Delayed Data·
493280 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18,49019,210
52 wk Range
13,190104,000
Key Statistics
Bid/Ask
18,540.00 / 18,620.00
Prev. Close
18,840
Open
18,910
Day's Range
18,490-19,210
52 wk Range
13,190-104,000
Volume
31.64K
Average Volume (3m)
93.15K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
493280 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

493280 Income Statement

Compare 493280 to Peers and Sector

Metrics to compare
493280
Peers
Sector
Relationship
P/E Ratio
0.0x−9.3x−0.4x
PEG Ratio
0.000.020.00
Price/Book
0.0x1.8x2.6x
Price / LTM Sales
0.0x7.1x3.1x
Upside (Analyst Target)
0.0%14.8%48.4%
Fair Value Upside
Unlock22.9%6.5%Unlock

IMBiologics Corp., a biotechnology company, engages in developing immunomodulatory antibody therapeutics to treat autoimmune diseases and cancer. The company uses Optimal Antibody Modality Manufacturing Technology (IM-OpDECon) for developing differentiated treatments for autoimmune diseases and immuno-oncology based on immuno-modulatory biologics. Its products include IMB-101, a bispecific therapeutic antibody that targets OX40L and TNF to modulate pathological immune mechanisms mediating Th1/Th17 immune responses; IMB-102; IMB-201, an antibody-drug conjugate that targets HLA-G, a tumor-specific antigen; IMB-402, a concept anticancer vaccine bispecific antibody that utilizes the ePENDY (IgM-Agonist) modality to activate cancer cell-specific T cells. IMBiologics Corp. was founded in 2020 and is based in Suwon-si, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
10.09M68.16%192.83B
Public Companies & Retail Investors
4.71M31.84%90.07B
Total
14.8M100.00%282.91B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Shinhan Venture Investment Co, Ltd.7.20%1,065,29420,357,768
Partners Investment Co., Ltd.6.05%896,05217,123,554

FAQ

What Is the Imbiologics (493280) Stock Price Today?

The Imbiologics stock price today is 18,550 KRW.

What Stock Exchange Does Imbiologics Trade On?

Imbiologics is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Imbiologics?

The stock symbol for Imbiologics is "493280."

What Is the Imbiologics Market Cap?

As of today, Imbiologics market cap is 278.91B KRW.

From a Technical Analysis Perspective, Is 493280 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Imbiologics Stock Split?

Imbiologics has split 0 times.

What is the current trading status of Imbiologics (493280)?

As of Aug 14, 2026, Imbiologics (493280) is trading at a price of 18,550 KRW, with a previous close of 18,840 KRW. The stock has fluctuated within a day range of 18,490 KRW to 19,210 KRW, while its 52-week range spans from 13,190 KRW to 104,000 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.